Josh Epstein

Josh Epstein is the current CEO at Stratevi. Josh was previously the Director of Medical Outcomes Research & Economics at Baxter International Inc. from July 2007 to July 2015. In this role, they were responsible for the strategic health economic & outcomes research planning and execution of tactical plan for the US & Global health economics/outcomes lead for $3.4b hematology franchise. This included 3 main marketed products, 3 launch products and 3 early-phase products. Josh also led cross-functional development & evolution of 6 product value propositions and managed and mentored a high performing team of 7 individuals.

Josh Epstein earned their PhD in Pharmaceutical Economics & Policy from the University of Southern California. Josh also holds a MA from USC. Prior to that, they completed their BS in Economics and Cell & Molecular Biology at the University of Washington.

Alex Ellis - Associate Director, Samira Massachi - Senior Manager, and Josephine Li-McLeod - Chief Strategy Officer report to Josh Epstein.